TrialBMC cancer2026

A phase II study of cabozantinib in metastatic or unresectable refractory gastrointestinal stromal tumour(GIST): a single-centre study from India.

Neelima Ventrapragada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.